Arifulla Khan

4.5k total citations
58 papers, 1.7k citations indexed

About

Arifulla Khan is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Arifulla Khan has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Psychiatry and Mental health, 16 papers in Pharmacology and 13 papers in Experimental and Cognitive Psychology. Recurrent topics in Arifulla Khan's work include Electroconvulsive Therapy Studies (18 papers), Treatment of Major Depression (14 papers) and Schizophrenia research and treatment (13 papers). Arifulla Khan is often cited by papers focused on Electroconvulsive Therapy Studies (18 papers), Treatment of Major Depression (14 papers) and Schizophrenia research and treatment (13 papers). Arifulla Khan collaborates with scholars based in United States, Sweden and Canada. Arifulla Khan's co-authors include Seth A. Cohen, Michael E. Thase, Björn Paulsson, William Chang, Richard H. Weisler, Wayne Macfadden, Joseph R. Calabrese, Narendra P. Singh, David L. Dünner and David Avery and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

Arifulla Khan

55 papers receiving 1.6k citations

Peers

Arifulla Khan
Comparison fields: 5 of 107
  • Psychiatry and Mental health 852
  • Pharmacology 535
  • Experimental and Cognitive Psychology 396
  • Clinical Psychology 324
  • Cognitive Neuroscience 155
K. Behnke Denmark
Ram Shrivastava United States
Alfredo Carlo Altamura Italy
S. Hoog United States
Mark D. Fossey United States
J M Perel United States
James L. Claghorn United States
Anna Åberg‐Wistedt Sweden
Steven K. Secunda United States
Joseph Mendels United States
K. Behnke Denmark View profile →
Citations per field, relative to Arifulla Khan
Arifulla Khan · 1×
Citations per year, relative to Arifulla Khan
Arifulla Khan · 1×

Countries citing papers authored by Arifulla Khan

Since Specialization
Citations

This map shows the geographic impact of Arifulla Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arifulla Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arifulla Khan more than expected).

Fields of papers citing papers by Arifulla Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arifulla Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arifulla Khan. The network helps show where Arifulla Khan may publish in the future.

Co-authorship network of co-authors of Arifulla Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Arifulla Khan. A scholar is included among the top collaborators of Arifulla Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arifulla Khan. Arifulla Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer’s disease The Journal of Prevention of Alzheimer s Disease James W. Kupiec, Raymond Scott Turner et al. 0
2 Cariprazine for the Adjunctive Treatment of Major Depressive Disorder: Results of a Randomized Phase 3 Placebo-Controlled Study (Study 301) CNS Spectrums Roy H. Perlis, Paul Yeung et al. 1
3 Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study Seminars in Arthritis and Rheumatism Thomas J. Schnitzer, Arifulla Khan et al. 15
4 Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression Journal of Clinical Psychopharmacology Michael E. Thase, Wayne Macfadden et al. 399
5 Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents Journal of the American Academy of Child & Adolescent Psychiatry Michael J. Labellarte, Joseph Biederman et al. 15
6 A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder Journal of Clinical Psychopharmacology Karl Rickels, Richard M. Mangano et al. 70
7 The Use of Venlafaxine in the Treatment of Major Depression and Major Depression Associated With Anxiety Journal of Clinical Psychopharmacology Arifulla Khan, G. Virginia Upton et al. 66
8 Dependency and self‐criticism in bipolar and unipolar depressed women British Journal of Clinical Psychology Irwin S. Rosenfarb, Joseph Becker et al. 49
9 Ethanol-induced single-strand DNA breaks in rat brain cells Mutation Research/Genetic Toxicology Narendra Singh, Henry Lai et al. 55
10 Acetaldehyde: genotoxicity and cytotoxicity in human lymphocytes Mutation Research/DNA Repair Narendra P. Singh, Arifulla Khan 99
11 Perceptions of parental and peer attachments by women with mood disorders. Journal of Abnormal Psychology Irwin S. Rosenfarb, Joseph Becker et al. 28
12 Can ECT-induced cognitive effects be altered pharmacologically? Progress in Neuro-Psychopharmacology and Biological Psychiatry Arifulla Khan et al. 13
13 Low‐Dose Thyrotropin‐Releasing Hormone Effects in Cognitively Impaired Alcoholics Alcoholism Clinical and Experimental Research Arifulla Khan, Keith H. Claypoole et al. 6
14 Is a single tricyclic antidepressant trial an active treatment for psychotic depression? Progress in Neuro-Psychopharmacology and Biological Psychiatry Arifulla Khan et al. 7
15 Morning or evening bright light treatment of winter depression? The significance of hypersomnia Biological Psychiatry David Avery, Arifulla Khan et al. 57
16 Antipsychotic effect of milieu in the acute treatment of schizophrenia General Hospital Psychiatry Seth A. Cohen, Arifulla Khan 16
17 Sleep is undisturbed in elderly, depressed individuals who have not sought health care Biological Psychiatry Michael V. Vitiello, Patricia N. Prinz et al. 23
18 Psychotic and nonpsychotic depression: comparison of response to ECT. PubMed Arifulla Khan, David Avery et al. 19
19 Hospitalization effect in acute mania General Hospital Psychiatry Seth A. Cohen, Arifulla Khan et al. 6
20 Adjunctive Benzodiazepines in Acute Schizophrenia Neuropsychobiology Seth A. Cohen, Arifulla Khan 12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026